Healthcare DIVE October 15, 2020
Dive Brief:
- The medtech market is projected to bounce back in the third quarter from the second, buoyed by a recovery in elective procedure volumes that occurred at a faster pace than initially anticipated, according to an outlook from Needham analysts.
- Needham forecast overall growth improving in the third quarter to negative 12.3% in major medtech markets, up from a 25.4 percent plunge during the second. Momentum is expected to carry into the fourth quarter, potentially bringing on positive growth, but the flu season poses a risk to the recovery. For the full year, analysts see the overall medtech market declining 11.2% compared to 2019.
- But there’s also evidence a recovery in non-coronavirus hospital patient volumes is flattening. Analysts...